Abciximab added to urokinase increased amputation-free survival in peripheral arterial occlusion of the legs
- PMID: 12093211
Abciximab added to urokinase increased amputation-free survival in peripheral arterial occlusion of the legs
Comment on
-
Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone--a randomized pilot trial (the PROMPT Study). Platelet Receptor Antibodies in Order to Manage Peripheral Artery Thrombosis.Radiology. 2001 Dec;221(3):689-96. doi: 10.1148/radiol.2213010400. Radiology. 2001. PMID: 11719664 Clinical Trial.